跳至主要内容
临床试验/JPRN-jRCT1042230052
JPRN-jRCT1042230052招募中Unknown

A Multicenter Prospective Randomized Interventional Study Examining the Impact of Wide Interlesion Distance in High Power Short Duration Atrial Fibrillation Ablation Using the TactiFlex - WILD PVI trial

aruse Yoshihisa0 个研究点目标入组 204 人开始时间: 2023年6月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
204

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • 1. patients between 20 and 80 years of age
  • 2. patients diagnosed with paroxysmal atrial fibrillation and scheduled for first catheter ablation procedure (using TactiFlex)
  • 3. Patients who have given their consent to participate in this study by signing a consent form in person.

排除标准

  • Patients who meet any of the following criteria will not be included in this study
  • 1. Patients with a history of catheter ablation for atrial fibrillation
  • 2. Patients with serious renal disease (on hemodialysis)
  • 3. women who are lactating, pregnant, or of childbearing potential
  • 4. patients with symptomatic heart failure (NYHA III degree or higher).

研究者

发起方
aruse Yoshihisa

相似试验